Gebelikte Kardiyovasküler Hastalıklara Aile Hekimi Gözünden Yaklaşım

Pierpont ME, Basson CT, Benson DW Jr et al. Genetic basis for congenital heart defects: Current knowledge. Circulation 2007;115:3015–3038.

Burchill L, Greenway S, Silversides CK et al. Genetic counseling in the adult with congenital heart disease: What is the role? Curr Cardiol Rep 2011;13:347–355.

Cowan JR, Ware SM. Genetics and genetic testing in congenital heart disease. Clin Perinatol 2015;42:373–393, ix.

Girerd B, Lau E, Montani D et al. Genetics of pulmonary hypertension in the clinic. Curr Opin Pulm Med 2017;23:386–391

Pijuan-Domenech A, Galian L, Goya M et al. Cardiac complications during pregnancy are better predicted with the modified who risk score. Int J Cardiol 2015;195:149–154

Ruys TP, Roos-Hesselink JW, Pijuan-Domenech A et al.Is a planned caesarean section in women with cardiac disease beneficial? Heart 2015;101:530–536.

Mandalenakis Z, Rosengren A, Skoglund K et al. Survivorship in children and young adults with congenital heart disease in Sweden. JAMA Intern Med 2017;177:224–230.

Sliwa K, van Hagen IM, Budts W et al. Pulmonary hypertension and pregnancy outcomes: Data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail 2016;18:1119–1128

Duan R, Xu X, Wang X et al. Pregnancy outcome in women with Eisenmenger’s syndrome: A case series from West china. BMC Pregnancy Childbirth 2016;16:356

Jondeau G, Ropers J, Regalado E et al. International registry of patients carrying TGFBR1 or TGFBR2 mutations: Results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet 2016;9:548–558

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal. 2018;39(34):3165-3241. doi:10.1093/eurheartj/ehy340

Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology. J Hypertens 2013; 31:1281–1357

Shekhar S, Gupta N, Kirubakaran R et al. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis. BJOG 2016;123:40–47.

Clark SM, Dunn HE, Hankins GD. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol 2015;39:548–555

Roos-Hesselink JW, Budts W, Walker F et al. Organisation of care for pregnancy in patients with congenital heart disease. Heart 017;103:1854–1859

Pijuan-Domenech A, Galian L, Goya M et al. Cardiac complications during pregnancy are better predicted with the modified who risk score. Int J Cardiol 2015;195:149–154

Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/aASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Cinical Practice Guidelines. Hypertension 2018;71:e13–e115